Read How Analysts Reacted To Cintas' Q4 Results
RBC Capital analyst Ashish Sabadra lowered the price target on Cintas Corp (NASDAQ: CTAS) to $450 (an upside of 16%) from $475, citing elevated macroeconomic uncertainty. Sabadra maintained the Outperform rating on the shares.
The analyst stated that CTAS' 4Q22 results beat expectations and provided strong FY23 revenue guidance. He believes revenues are more resilient than the prior downturn, namely the Global Financial Crisis in 2008.
Sabadra believes that cross-selling opportunities, robust pricing, share gains, improved retention, and large vertical opportunities such as healthcare/education/government bode well for growth.
Related: Cintas Q4 Earnings Top Estimates
The analyst sees fuel headwinds abating, lower than his estimate of 38bps, where these headwinds could lessen if oil continues to decline.
Low net leverage (<2x) provides significant buyback and M&A opportunities, Sabadra added.
Morgan Stanley analyst Toni Kaplan raised the price target on Cintas to $362 (a downside of 6.5%) from $357 while maintaining the Equal-Weight rating on the shares.
Price Action: CTAS shares are trading higher by 0.10% at $387.52 on the last check Friday.
Latest Ratings for CTAS
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | Morgan Stanley | Maintains | Equal-Weight | |
Dec 2021 | Argus Research | Maintains | Buy | |
Dec 2021 | Morgan Stanley | Maintains | Equal-Weight |
View More Analyst Ratings for CTAS
View the Latest Analyst Ratings
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.